Pharma Stocks
-
Is its NASH pipeline strong enough to unlock biotech up
Hepion Pharmaceuticals focuses on innovative treatments for metabolic liver diseases like NASH, offering U.S. investors targeted exposure to a high-growth…
Read More » -
We’re Hopeful That Solasia Pharma K.K (TSE:4597) Will Use Its Cash Wisely
Even when a business is losing money, it’s possible for shareholders to make money if they buy a good business…
Read More » -
Is pharma packaging demand strong enough to drive steady gains
With global pharma growth accelerating amid AI-driven drug discovery and supply chain shifts, can Gerresheimer’s specialized packaging position deliver reliable…
Read More » -
Amneal shares rise after UBS initiates at Buy, cites “best-in-group” growth in specialty pharma
Amneal shares rise after UBS initiates at Buy, cites “best-in-group” growth in specialty pharma Proactive uses images sourced from Shutterstock…
Read More » -
Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?
TradingKey – On April 16, 2026, OpenAI released GPT-Rosalind, a large language model specifically designed for life sciences research. Initial…
Read More » -
Top stocks in news: Wipro, HDFC Life, Jio Financial, Auro Pharma, RVNL, AngelOne, Om Power
Indian benchmark indices settled lower, giving up early gains in the fag end of the session, as trader book profits…
Read More » -
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
Key Points All three drugmakers have proven fairly innovative in their respective niches. Clinical and commercial progress could send their…
Read More » -
Is pharma packaging demand strong enough to drive sustained ga
With global biopharma growth fueling demand for specialized packaging, you need to know if Gerresheimer’s position delivers reliable returns for…
Read More » -
Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed M…
Technical Trend Overview and Price Movement The pharmaceutical and biotechnology company, currently priced at ₹148.55, has seen its technical trend…
Read More » -
Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check details
Investors looking to participate in Aurobindo Pharma‘s share buyback worth Rs 800 crore will likely have to purchase the shares…
Read More »